ZIVO Bioscience Enters Pilot Program to Expand Production Into Europe

ZIVO Bioscience (OTCMKTS:ZIVO) contracted with Algatek, to conduct a pilot program using proprietary Algatek production technology.
As quoted in the press release:

Algatek operates a fully-licensed food-pharma grade facility that will be able to certify ZIVO products and help streamline compliance in the Eurozone and Middle East regulatory environments, expanding potential markets for the Company’s offerings.

Last week, Algatek successfully introduced the ZIVO strain into its production environment at the facility located in Asturias, Spain and will commence scale-up over the next few weeks, when it is expected to cultivate the ZIVO strain in its commercial-scale 96 meter photobioreactors.

Click here to read the full press release.

Source: globenewswire.com